Incruse Ellipta and Insulin Degludec (U-200) Prefilled Pens
Determining the interaction of Incruse Ellipta and Insulin Degludec (U-200) Prefilled Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: umeclidinium
Brand name: Incruse Ellipta
Synonyms: n.a.
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Incruse Ellipta-Insulin degludec and liraglutide
- Incruse Ellipta-Insulin degludec and liraglutide Subcutaneous
- Incruse Ellipta-Insulin degludec Subcutaneous
- Incruse Ellipta-Insulin detemir
- Incruse Ellipta-Insulin Detemir (Cartridges and Prefilled Syringes)
- Incruse Ellipta-Insulin Detemir (Vials)
- Insulin Degludec (U-200) Prefilled Pens-Indacaterol
- Insulin Degludec (U-200) Prefilled Pens-Indacaterol and Glycopyrrolate
- Insulin Degludec (U-200) Prefilled Pens-Indacaterol and glycopyrrolate Inhalation
- Insulin Degludec (U-200) Prefilled Pens-Indacaterol inhalation
- Insulin Degludec (U-200) Prefilled Pens-Indacaterol Maleate
- Insulin Degludec (U-200) Prefilled Pens-Indapamide